dabigatran etexilate

Poland

Drugs containing this active substance

  • ABAGAT

    In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, this medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 86.48 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health, S.L.U. SAG Manufacturing S.L.U.

  • The medicine is used in adults to prevent blood clots after hip or knee surgery, to reduce the risk of blood clots in the brain and body in people with atrial fibrillation, and to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 126.83 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health, S.L.U. SAG Manufacturing S.L.U.

  • The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation) and for the treatment and prevention of recurrence of clots in the veins of the legs and lungs. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 172.95 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health, S.L.U. SAG Manufacturing S.L.U.

  • The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children aged 8 years and older, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Adamed Pharma S.A.

  • The medicinal product is used in adults to prevent blood clots after hip or knee surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg veins and lungs. In children over 8 years of age, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Adamed Pharma S.A.

  • Bigetra is used in adults to prevent strokes and blood clots (in atrial fibrillation) and in the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children over 8 years of age, it is used to treat and prevent the recurrence of blood clots.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Adamed Pharma S.A.

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 86.48 mg

    ATC: B01AE07

    Manufacturer: Pharmadox Healthcare Ltd., TOWA Pharmaceuticals Europe, S.L.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg veins and lungs. In children, the medicine is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 126.83 mg

    ATC: B01AE07

    Manufacturer: Pharmadox Healthcare Ltd., TOWA Pharmaceuticals Europe, S.L.

  • This medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of blood clots in the veins of the legs and lungs. In children, it is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 172.95 mg

    ATC: B01AE07

    Manufacturer: Pharmadox Healthcare Ltd., TOWA Pharmaceuticals Europe, S.L.

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children aged 8 years and older, it is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children over 8 years of age, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Adamed Pharma S.A.

  • In adults, it is used to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children over 8 years of age, it is used for the treatment and prevention of recurrence of blood clots.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Adamed Pharma S.A.

  • In adults, it is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Laboratorios Liconsa S.A.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Laboratorios Liconsa S.A.

  • This medicine is used in adults to prevent blood clots in the brain (stroke) and other blood vessels in atrial fibrillation, and to treat and prevent the recurrence of blood clots in the veins of the legs and lungs. In children, it is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Laboratorios Liconsa S.A.

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Laboratorios Liconsa S.A.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Laboratorios Liconsa S.A.

  • The medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of blood clots in the leg veins and lungs. In children, it is used to treat and prevent the recurrence of blood clots.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Laboratorios Liconsa S.A.

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Laboratorios Liconsa S.A.

  • The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, to prevent strokes and clots in other vessels in people with atrial fibrillation, and to treat and prevent the recurrence of clots in the leg and lung veins. In children, it is used to treat clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Laboratorios Liconsa S.A.

  • This medicine is used in adults to prevent blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation with an additional risk factor), as well as to treat and prevent the recurrence of clots in the veins of the legs and lungs. In children, the medicine is used to treat clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Laboratorios Liconsa S.A.

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 86.48 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health S.L. SAG Manufacturing S.L.U.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 126.83 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health S.L. SAG Manufacturing S.L.U.

  • The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, it is used for the treatment and prevention of recurrence of blood clots.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 172.95 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health S.L. SAG Manufacturing S.L.U.

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Orion Corporation Orion Pharma

  • This medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Orion Corporation Orion Pharma

  • In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Orion Corporation Orion Pharma

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 86.48 mg

    ATC: B01AE07

    Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Limited

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 126.83 mg

    ATC: B01AE07

    Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Limited

  • In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used for the treatment and prevention of recurrence of blood clots.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 172.95 mg

    ATC: B01AE07

    Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Limited

  • In adults, it is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health, S.L.U. SAG MANUFACTURING, S.L.U.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health, S.L.U. SAG MANUFACTURING, S.L.U.

  • In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health, S.L.U. SAG MANUFACTURING, S.L.U.

  • This medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and in the treatment and prevention of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat and prevent recurrences of blood clots.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Betapharm Arzneimittel GmbH

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Betapharm Arzneimittel GmbH

  • In adults, this medicine is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, it is used to treat blood clots and to prevent them from recurring.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Betapharm Arzneimittel GmbH

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 86.48 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health S.L. Pharmadox Healthcare Limited SAG Manufacturing S.L.U. STADA Arzneimittel AG

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes and blood clots in other vessels in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 126.83 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health S.L. Pharmadox Healthcare Limited SAG Manufacturing S.L.U. STADA Arzneimittel AG

  • The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation) and to treat and prevent the recurrence of clots in the veins of the legs and lungs. In children, the medicine is used to treat clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 1472.95 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health S.L. Pharmadox Healthcare Limited SAG Manufacturing S.L.U. Stada AG

  • In adults, it is used to prevent the formation of blood clots in the veins following knee or hip replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.

  • The medicine is used in adults to prevent blood clots after knee or hip replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.

  • In adults, it is used to prevent strokes and blood clots (in cases of irregular heart rhythm) and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, it is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 86.4808 mg

    ATC: B01AE07

    Manufacturer: Pharmathen International S.A.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 126.8384 mg

    ATC: B01AE07

    Manufacturer: Pharmathen International S.A.

  • The medicine is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used for the treatment and prevention of recurrence of blood clots.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 172.9615 mg

    ATC: B01AE07

    Manufacturer: Pharmathen International S.A.

  • In adults, it is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, this medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Krka d.d., Novo mesto

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and in the treatment and prevention of recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Krka d.d., Novo mesto

  • The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of clots in the veins of the legs and lungs. In children, it is used to treat clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Krka d.d., Novo mesto

  • In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, this medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health S.L.U., SAG MANUFACTURING, S.L.U.

  • The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes and clots in other vessels (in people with atrial fibrillation and additional risk), and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health S.L.U., SAG MANUFACTURING, S.L.U.